Mohammad Azab - Net Worth and Insider Trading
Mohammad Azab Net Worth
The estimated net worth of Mohammad Azab is at least $2 Million dollars as of 2024-11-13. Mohammad Azab is the Director of Xenon Pharmaceuticals Inc and owns about 57,561 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $2 Million. Mohammad Azab is also the Director of Durect Corp and owns about 3,000 shares of Durect Corp (DRRX) stock worth over $3,870. Details can be seen in Mohammad Azab's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mohammad Azab has not made any transactions after 2022-05-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mohammad Azab
Mohammad Azab Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mohammad Azab owns 4 companies in total, including Xenon Pharmaceuticals Inc (XENE) , Novelion Therapeutics Inc (NVLNF) , and Durect Corp (DRRX) among others .
Click here to see the complete history of Mohammad Azab’s form 4 insider trades.
Insider Ownership Summary of Mohammad Azab
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2019-09-13 | director |
| NVLNF | Novelion Therapeutics Inc | 2005-05-24 | Exec VP-R&D & CMO |
| DRRX | Durect Corp | 2022-05-17 | director |
 | | 2022-09-15 | director |
Mohammad Azab Latest Holdings Summary
Mohammad Azab currently owns a total of 2 stocks. Among these stocks, Mohammad Azab owns 57,561 shares of Xenon Pharmaceuticals Inc (XENE) as of September 13, 2019, with a value of $2 Million and a weighting of 99.85%. Mohammad Azab also owns 3,000 shares of Durect Corp (DRRX) as of May 17, 2022, with a value of $3,870 and a weighting of 0.15%.
Latest Holdings of Mohammad Azab
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2019-09-13 | 57,561 | 43.36 | 2,495,845 |
| DRRX | Durect Corp | 2022-05-17 | 3,000 | 1.29 | 3,870 |
Holding Weightings of Mohammad Azab
Mohammad Azab Form 4 Trading Tracker
According to the SEC Form 4 filings, Mohammad Azab has made a total of 0 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 23 shares on September 13, 2019, which brought Mohammad Azab around $214.
According to the SEC Form 4 filings, Mohammad Azab has made a total of 1 transactions in Durect Corp (DRRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Durect Corp is the acquisition of 3,000 shares on May 17, 2022, which cost Mohammad Azab around $12,300.
Insider Trading History of Mohammad Azab
- 1
Mohammad Azab Trading Performance
GuruFocus tracks the stock performance after each of Mohammad Azab's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mohammad Azab is 35.09%. GuruFocus also compares Mohammad Azab's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mohammad Azab within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mohammad Azab's insider trading performs compared to the benchmark.
Performance of Mohammad Azab
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.32 | | | | | |
| Relative Return to S&P 500(%) | 11.23 | | | | | |
Mohammad Azab Ownership Network
Ownership Network List of Mohammad Azab
Ownership Network Relation of Mohammad Azab
Mohammad Azab Owned Company Details
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
Mohammad Azab is the director of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include SVP Bus. & Corp. Development Sherrington Robin , director & PRESIDENT & CEO Ian Mortimer , and Chief Medical Officer Christopher John Kenney .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, Mohammad Azab made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 26,576 shares made by Gary Patou , a net sale of 131,245 shares made by Simon N. Pimstone , and a net sale of 31,655 shares made by Ian Mortimer .
In summary, during the past 3 months, insiders sold 0 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 236,705 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 236,705 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
Mohammad Azab Mailing Address
Above is the net worth, insider trading, and ownership report for Mohammad Azab. You might contact Mohammad Azab via mailing address: C/o Supergen, Inc., 4140 Dublin Blvd., Suite 200, Dublin Ca 94568.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
